WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SAGE

Based on 8 analysts offering 12 month price targets for Sage Therapeutics Inc

Min Forecast
$4.00-45.13%
Avg Forecast
$8.25+13.17%
Max Forecast
$12.00+64.61%

Should I buy or sell SAGE stock?

Based on 8 analysts offering ratings for Sage Therapeutics Inc.

Hold
Strong Buy
1 analysts 12.5%
Buy
1 analysts 12.5%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SAGE's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates SAGE as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SAGE stock forecasts and price targets.

SAGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-12
lockedlocked$00.00+00.00%2025-02-12
lockedlocked$00.00+00.00%2025-02-12
lockedlocked$00.00+00.00%2025-02-12
lockedlocked$00.00+00.00%2025-01-02
Stifel Nicolaus
Bottom 4%
4
HoldMaintains$6.00-17.70%2024-12-16
TD Cowen
Bottom 3%
3
HoldMaintains$9.00+23.46%2024-11-21
RBC Capital
Bottom 4%
4
HoldUpgrades$4.00-45.13%2024-11-21

1 of 1

Forecast return on equity

Is SAGE forecast to generate an efficient return?

Company
-18.18%
Industry
142.9%
Market
80.27%
SAGE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SAGE forecast to generate an efficient return on assets?

Company
-15.87%
Industry
35.65%
SAGE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SAGE earnings per share forecast

What is SAGE's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$3.38
Avg 2 year Forecast
-$2.45
Avg 3 year Forecast
-$1.49

SAGE revenue forecast

What is SAGE's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$81.6M+72.11%
Avg 2 year Forecast
$122.9M+159.22%
Avg 3 year Forecast
$160.5M+238.64%
SAGE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SAGE revenue growth forecast

How is SAGE forecast to perform vs Biotechnology companies and vs the US market?

Company
50.4%
Industry
64.17%
Market
10.07%
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SAGE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAGE$7.29$8.25+13.17%Hold
PGEN$1.56$6.00+284.62%Buy
AMLX$5.11$10.00+95.69%Buy
ABVX$7.12$26.00+265.17%Buy
EYPT$6.82$29.33+330.10%Strong Buy
View Top Biotech Stocks

Sage Therapeutics Stock Forecast FAQ

Is Sage Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: SAGE) stock is to Hold SAGE stock.

Out of 8 analysts, 1 (12.5%) are recommending SAGE as a Strong Buy, 1 (12.5%) are recommending SAGE as a Buy, 6 (75%) are recommending SAGE as a Hold, 0 (0%) are recommending SAGE as a Sell, and 0 (0%) are recommending SAGE as a Strong Sell.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.

What is SAGE's earnings growth forecast for 2025-2027?

(NASDAQ: SAGE) Sage Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Sage Therapeutics's earnings in 2025 is -$354,397,000.On average, 11 Wall Street analysts forecast SAGE's earnings for 2025 to be -$211,770,663, with the lowest SAGE earnings forecast at -$274,904,847, and the highest SAGE earnings forecast at -$103,950,352. On average, 11 Wall Street analysts forecast SAGE's earnings for 2026 to be -$153,533,418, with the lowest SAGE earnings forecast at -$269,895,191, and the highest SAGE earnings forecast at -$23,169,657.

In 2027, SAGE is forecast to generate -$93,392,503 in earnings, with the lowest earnings forecast at -$179,095,185 and the highest earnings forecast at $20,038,622.

What is SAGE's revenue growth forecast for 2025-2027?

(NASDAQ: SAGE) Sage Therapeutics's forecast annual revenue growth rate of 50.4% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Sage Therapeutics's revenue in 2025 is $47,404,000.On average, 9 Wall Street analysts forecast SAGE's revenue for 2025 to be $5,109,034,561, with the lowest SAGE revenue forecast at $3,890,623,718, and the highest SAGE revenue forecast at $7,282,786,712. On average, 9 Wall Street analysts forecast SAGE's revenue for 2026 to be $7,694,956,120, with the lowest SAGE revenue forecast at $4,208,110,637, and the highest SAGE revenue forecast at $10,338,676,579.

In 2027, SAGE is forecast to generate $10,052,437,387 in revenue, with the lowest revenue forecast at $7,430,571,550 and the highest revenue forecast at $14,164,800,983.

What is SAGE's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SAGE) forecast ROA is -15.87%, which is lower than the forecast US Biotechnology industry average of 35.65%.

What is SAGE's Price Target?

According to 8 Wall Street analysts that have issued a 1 year SAGE price target, the average SAGE price target is $8.25, with the highest SAGE stock price forecast at $12.00 and the lowest SAGE stock price forecast at $4.00.

On average, Wall Street analysts predict that Sage Therapeutics's share price could reach $8.25 by Feb 12, 2026. The average Sage Therapeutics stock price prediction forecasts a potential upside of 13.17% from the current SAGE share price of $7.29.

What is SAGE's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SAGE) Sage Therapeutics's current Earnings Per Share (EPS) is -$5.80. On average, analysts forecast that SAGE's EPS will be -$3.38 for 2025, with the lowest EPS forecast at -$4.39, and the highest EPS forecast at -$1.66. On average, analysts forecast that SAGE's EPS will be -$2.45 for 2026, with the lowest EPS forecast at -$4.31, and the highest EPS forecast at -$0.37. In 2027, SAGE's EPS is forecast to hit -$1.49 (min: -$2.86, max: $0.32).

What is SAGE's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SAGE) forecast ROE is -18.18%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.